Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable?

That is the topic of a recent BioSpace article titled “How Effective Will TrumpRx and Other Direct-to-Consumer Drug Pricing Initiatives Be?” A am quoted in the article as follows: While [direct-to-consumer] DTC has been a growing trend in biopharma for nearly two years now—Lilly launched LillyDirect in January 2024—the number of drugmakers looking to sell their…

Read More

How does hospital participation in a Medicare Advantage preferred network impact commercial reimbursement?

How does a hospital’s participation in a health plan’s Medicare Advantage (MA) provider network impact their commercial rates? Since many insurers offer both MA plans and commercial plans, there could be spillovers with respect to negotiating. How would MA network participation impact commercial rates? Marr et al. (2025) offers some hypotheses: On the one hand,…

Read More

Links

Only ⅔ of FDA-approved biosimilars have launched.Measles outbreak continues.UnitedHealth profits fall.Super-Earths.‘Bone Collector’ caterpillars.NFL Draft comes to Green Bay.

Read More

Peter Yellowlees, Asynch Health

Peter Yellowlees MD is CEO at Asynch Health–this is a new company that is doing the intake interview for a psychiatrist or psychologist session. Peter demos how the AI agent asks questions, how a patient answers in real time. Then after submitting the answers, the AI creates both a full transcript in the back end,…

Read More